CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth takes a stake in T2S

CDG Invest Growth takes a stake in T2S (Techniques Science Santé), Morocco’s leading distributor of high tech medical equipment.

T2S, the leader in the distribution and the maintenance of medical equipment

Founded in 1992, T2S assists healthcare professionals in the installation, training for utilisation and maintenance of high technology medical equipment. T2S distributes in Morocco products from General Electric Healthcare, Varian Medical Systems, Zeiss, B Braun, Getinge, Aesculap as well as other brands.  Since its creation, T2S has built a strong reputation in radiology (scanners, MRIs…) and oncology (linacs for radiotherapy) and has today the largest installed base in Morocco in high tech medical equipment.

The company has historically built its reputation in the nineties by assisting private doctors in opening their first medical offices and has accompanied these same doctors when they opened larger clinics.  It is now the preferred partner of healthcare professionals for their development projects.

With its large product range, T2S can now propose turnkey solutions for multi-specialty clinics and hospitals and can therefore provide a one stop shop solution for its customers, from the planning of the site, the installation of the equipment, the training of the teams and eventually the maintenance.

In Morocco, T2S has participated in several structural health projects both on the public and private side, including several CHUs (centres hospitaliers universitaires) as well as large hospitals built by international foundations (Fondation Cheikh Khalifa Ibn Zaid in Casablanca and Fondation Cheikh Zaid in Rabat).

African Track Record

Since 2008, T2S has expanded outside Morocco and has equipped the first radiotherapy, oncology and nuclear medicine center in Mauritania.  This successful experience enabled the company to equip other medical centers in Mauritania with radiology equipment.  T2S is also active in Ivory Coast and Mali and is currently exploring new opportunities in other African countries.

A partnership to strengthen the company

The company has the ambition to pursue its growth and further cement its leadership position. Abderraouf Sordo, the founder and CEO of T2S said “We are very optimistic about the outlook of the healthcare sector in our region and the role of medical equipment to succeed. Our partnership with CDG Invest Growth will give us an institutional investor as well as a hands-on partner that will help us achieve our growth and development targets”

Brahim Guessous, Partner at CDG Invest Growth who lead the deal commented “we have been impressed by what has been accomplished by this great team over the last 25 years. In the context of the liberalisation of the healthcare sector in Morocco and the opportunities we see in Africa, we are confident in the growth potential of T2S.  With already high ESG standards, this company can continue to play a key role in the development of the healthcare industry, thereby impacting positively the communities it serves”.

In 2015, T2S made c.€40m of annual turnover and had 140 employees. CDG Invest Growth took a minority stake in T2S.

Click here for more information about T2S

With an investment return of 3.3 money multiple, CDG Invest Growth has announced its total exit from Jet Contractors through a sale of shares on the Casablanca Stock Exchange. “CDG Invest Growth has contributed to the organic and structural development of Jet Contractors and has supported its integration of the value chain to become one […]

CDG Invest Growth takes a stake in Maymana, a leading company operating in bakery, pastry, fine stores and high-end catering. Maymana, a major bakery, pastry, fine grocery and high-end catering company Founded in 1985 by Mrs. Naima Berrada Benchakroun with the ambition to help empower women in Morocco, Maymana is today a major high-end catering […]

29 July 2021 CDG Invest Growth (“CIG”), the leading Morocco based private equity firm previously known as CDG Capital Private Equity, and Techniques Science-Santé (“T2S”), IM Alliance, Cyclopharma and Binarios (together, the “Company” or the “Group”) are pleased to announce the signing of an agreement for the sale of a majority stake in the largest […]